← FDA Drug Approvals (Drugs@FDA)

OSELTAMIVIR PHOSPHATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2021-08-30

Drug application

FDA Application #

ANDA212858

Application type

Abbreviated New Drug Application (Generic)

Brand name

OSELTAMIVIR PHOSPHATE

Generic name

OSELTAMIVIR PHOSPHATE

Active ingredients

OSELTAMIVIR PHOSPHATE

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

INVAGEN PHARMS

Manufacturer

Exelan Pharmaceuticals, Inc.

First approval

2021-08-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown